FRET Molecular Construct for Botulinum Neurotoxin Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting botulinum neurotoxins are either time-consuming, require large numbers of animals, or are complicated and expensive, making them unsuitable for sensitive and rapid detection, as well as for studying toxin catalytic kinetics or screening for inhibitors.
Innovation Solution
A molecular construct using fluorescent resonance energy transfer (FRET) with a linker peptide that is a substrate of botulinum neurotoxin, comprising a donor and acceptor fluorophore moiety, allowing for the detection of botulinum neurotoxins by monitoring the change in FRET signal when the linker peptide is cleaved by the toxin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mouse toxicity assay is used to detect botulinum neurotoxins, then detection sensitivity is improved, but detection time and animal usage increase significantly
Solution Approach 1:
The patent replaces the biological mechanical system of mouse toxicity assays with a biochemical FRET-based detection system. The molecular construct uses fluorophore energy transfer to detect toxin-catalyzed substrate cleavage, eliminating the need for live animal testing while maintaining high sensitivity through optical signal measurement.
Solution Approach 2:
The patent creates a simplified in vitro model that copies the essential biochemical function of toxin-substrate interaction. By using a synthetic peptide substrate with FRET moieties that mimics the native substrate cleavage event, the system reproduces the toxicological effect in a controlled, rapid, and animal-free manner.
2Measurement precision
If amplified immunoassay systems are used to detect botulinum neurotoxins, then detection sensitivity is improved, but assay complexity and cost increase
Solution Approach 1:
The patent extracts only the essential detection function from complex immunoassay systems. By directly measuring the biochemical consequence of toxin activity (substrate cleavage) through FRET signal change, the method eliminates unnecessary amplification steps, antibody conjugations, and complex readout procedures while maintaining sensitivity.
Solution Approach 2:
The patent changes the detection parameter from antibody binding signals to fluorophore energy transfer efficiency. This parameter change allows direct measurement of substrate cleavage events, simplifying the assay while improving sensitivity through the high signal-to-noise ratio of FRET measurements.
3Measurement precision
If HPLC and immunoassay are used to detect cleaved substrate molecules, then enzymatic activity measurement is improved, but detection time and procedural complexity increase
Solution Approach 1:
The patent enables continuous real-time monitoring of enzymatic activity through time-resolved FRET measurements. Unlike discrete HPLC or endpoint immunoassays, the FRET system provides continuous kinetic data, allowing multiple measurements without sample removal or procedural interruption, thereby maximizing throughput.
Solution Approach 2:
The patent introduces FRET fluorophores as optical intermediaries that translate the biochemical cleavage event into a measurable signal. This intermediary system allows direct, real-time detection of enzymatic activity without requiring sample processing, separation, or complex detection steps.
4Measurement precision
If peptide synthesis with modified amino acid derivatives is used for toxin detection, then detection capability is improved, but applicability to living cells is reduced
Solution Approach 1:
The patent designs a universal detection platform using FRET-based molecular constructs that can function in multiple contexts. The same basic design principle applies whether the substrate is a synthetic peptide in vitro or a genetically encoded protein in living cells, making the method broadly applicable across different experimental systems.
Solution Approach 2:
The patent enables the detection system to serve itself by using the toxin's own catalytic activity to generate the detection signal. The toxin cleaves the substrate, and this cleavage event directly produces the FRET signal change, eliminating the need for separate detection reagents or modifications that would limit cellular applicability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and sensitive detection of botulinum neurotoxins at pico-molar levels within hours, allowing for real-time monitoring of toxin enzymatic kinetics and high-throughput screening of inhibitors, suitable for use in living cells and neurons.
Implementation Method 1
A molecular construct using fluorescent resonance energy transfer (FRET) with a linker peptide that is a substrate of botulinum neurotoxin, comprising a donor and acceptor fluorophore moiety
Data Source
AI summary
A molecular construct capable of fluorescent resonance energy transfer (FRET), comprising a linker peptide, a donor fluorophore moiety and an acceptor fluorophore moiety, wherein the linker peptide is a substrate of a botulinum neurotoxin selected from the group consisting of synaptobrevin, syntaxin and SNAP-25, or a fragment thereof capable being cleaved by the botulinum neurotoxin, and separates the donor and acceptor fluorophores by a distance of not more than 10 nm, and wherein emission spectrum of the donor fluorophore moiety overlaps with the excitation spectrum of the acceptor fluorophore moiety; or wherein the emission spectra of the fluorophores are detectably different. Also provided are isolated nucleic acid expressing the construct, kits comprising said construct and cell lines comprising said nucleic acid. Further provided are methods of detecting a BoNT using the above described construct via FRET, and methods for detecting a BoNT using surface plasmon resonance imaging.